Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2021

Open Access 01-12-2021 | Neonatal Hypoglycemia | Research article

Safe threshold of capillary blood glucose for predicting early future neonatal hypoglycaemia in babies born to mothers with gestational diabetes mellitus, an observational, retrospective cohort study

Authors: Esther H. G. Park, Frances O’Brien, Fiona Seabrook, Jane Elizabeth Hirst

Published in: BMC Pregnancy and Childbirth | Issue 1/2021

Login to get access

Abstract

Background

There is increasing pressure to get women and babies home rapidly after birth. Babies born to mothers with gestational diabetes mellitus (GDM) currently get 24-h inpatient monitoring. We investigated whether a low-risk group of babies born to mothers with GDM could be defined for shorter inpatient hypoglycaemia monitoring.

Methods

Observational, retrospective cohort study conducted in a tertiary maternity hospital in 2018. Singleton, term babies born to women with GDM and no other risk factors for hypoglycaemia, were included. Capillary blood glucose (BG) testing and clinical observations for signs of hypoglycaemia during the first 24-h after birth. BG was checked in all babies before the second feed. Subsequent testing occurred if the first result was < 2.0 mmol/L, or clinical suspicion developed for hypoglycaemia. Neonatal hypoglycaemia, defined as either capillary or venous glucose ≤ 2.0 mmol/L and/or clinical signs of neonatal hypoglycaemia requiring oral or intravenous dextrose (lethargy, abnormal feeding behaviour or seizures).

Results

Fifteen of 106 babies developed hypoglycaemia within the first 24-h. Maternal and neonatal characteristics were not predictive. All babies with hypoglycaemia had an initial capillary BG ≤ 2.6 mmol/L (Area under the ROC curve (AUC) 0.96, 95% Confidence Interval (CI) 0.91–1.0). This result was validated on a further 65 babies, of whom 10 developed hypoglycaemia, in the first 24-h of life.

Conclusion

Using the 2.6 mmol/L threshold, extended monitoring as an inpatient could have been avoided for 60% of babies in this study. Whilst prospective validation is needed, this approach could help tailor postnatal care plans for babies born to mothers with GDM.
Literature
1.
go back to reference International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019. International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation, 2019.
2.
go back to reference Cheung NW. The management of gestational diabetes. Vasc Health Risk Manag. 2009;5(1):153–64.CrossRef Cheung NW. The management of gestational diabetes. Vasc Health Risk Manag. 2009;5(1):153–64.CrossRef
3.
go back to reference Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. N Engl J Med. 2005;352:2477–86.CrossRef Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. N Engl J Med. 2005;352:2477–86.CrossRef
4.
go back to reference Harris DL, Weston PJ, Gamble GD, Harding JE. Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose Well Babies (GLOW) Study. J Pediatr. 2020;223:34–41.CrossRef Harris DL, Weston PJ, Gamble GD, Harding JE. Glucose Profiles in Healthy Term Infants in the First 5 Days: The Glucose Well Babies (GLOW) Study. J Pediatr. 2020;223:34–41.CrossRef
5.
go back to reference Harris DL, Weston PJ, Harding JE. Incidence of Neonatal Hypoglycaemia in Babies Identified as at Risk. J Pediatr. 2012;161:787–91.CrossRef Harris DL, Weston PJ, Harding JE. Incidence of Neonatal Hypoglycaemia in Babies Identified as at Risk. J Pediatr. 2012;161:787–91.CrossRef
6.
go back to reference Voormolen DN, de Wit L, van Rijn BB, DeVries JH, Heringa MP, Franx A, Groenendaal F, Lamain-de RM. Neonatal Hypoglycemia Following Diet-Controlled and Insulin-Treated Gestational Diabetes Mellitus. Diabetes Care. 2018;41(7):1385–90.CrossRef Voormolen DN, de Wit L, van Rijn BB, DeVries JH, Heringa MP, Franx A, Groenendaal F, Lamain-de RM. Neonatal Hypoglycemia Following Diet-Controlled and Insulin-Treated Gestational Diabetes Mellitus. Diabetes Care. 2018;41(7):1385–90.CrossRef
7.
go back to reference Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC. Controversies Regarding Definition of Neonatal Hypoglycaemia: Suggested Operational Thresholds. Pediatrics. 2000;105:1141–5.CrossRef Cornblath M, Hawdon JM, Williams AF, Aynsley-Green A, Ward-Platt MP, Schwartz R, Kalhan SC. Controversies Regarding Definition of Neonatal Hypoglycaemia: Suggested Operational Thresholds. Pediatrics. 2000;105:1141–5.CrossRef
10.
go back to reference Identification and Management of Neonatal Hypoglycaemia in the Term Infant: A Framework for Practice. British Association of Perinatal Medicine, 2017. Identification and Management of Neonatal Hypoglycaemia in the Term Infant: A Framework for Practice. British Association of Perinatal Medicine, 2017.
13.
go back to reference Metzger BE, Persson B, Lowe LP, Dyer AR, Cruickshank JK, Deerochanawong C, Halliday HL, Hennis AJ, Liley H, Ng PC, Coustan DR, Hadden DR, Hod M, Oats JJN and Trimble ER for the HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome Study: Neonatal Glycemia. Pediatrics. 2010;126(6):e1545–52 Metzger BE, Persson B, Lowe LP, Dyer AR, Cruickshank JK, Deerochanawong C, Halliday HL, Hennis AJ, Liley H, Ng PC, Coustan DR, Hadden DR, Hod M, Oats JJN and Trimble ER for the HAPO Study Cooperative Research Group. Hyperglycaemia and Adverse Pregnancy Outcome Study: Neonatal Glycemia. Pediatrics. 2010;126(6):e1545–52
14.
go back to reference Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7.CrossRef Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7.CrossRef
15.
go back to reference Simeonova-Krstevska S, Bogoev M, Bogoeva K, Zisovska E, Samardziski I, Velkoska-Nakova V, Livrinova V, Todorovska I, Sima A, Blazevska-Siljanoska V. Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin. Open Access Maced J Med Sci. 2018;6(5):803–7.CrossRef Simeonova-Krstevska S, Bogoev M, Bogoeva K, Zisovska E, Samardziski I, Velkoska-Nakova V, Livrinova V, Todorovska I, Sima A, Blazevska-Siljanoska V. Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin. Open Access Maced J Med Sci. 2018;6(5):803–7.CrossRef
16.
go back to reference Tertti K, Ekblad U, Vahlberg T, Ronnemaa T. Comparison of Metformin and Insulin in the Treatment of Gestational Diabetes: A Retrospective Case-Control Study. Rev Diabet Stud. 2008;5(2):95–101.CrossRef Tertti K, Ekblad U, Vahlberg T, Ronnemaa T. Comparison of Metformin and Insulin in the Treatment of Gestational Diabetes: A Retrospective Case-Control Study. Rev Diabet Stud. 2008;5(2):95–101.CrossRef
Metadata
Title
Safe threshold of capillary blood glucose for predicting early future neonatal hypoglycaemia in babies born to mothers with gestational diabetes mellitus, an observational, retrospective cohort study
Authors
Esther H. G. Park
Frances O’Brien
Fiona Seabrook
Jane Elizabeth Hirst
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2021
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-021-03973-5

Other articles of this Issue 1/2021

BMC Pregnancy and Childbirth 1/2021 Go to the issue